A newly described cutaneous reaction at sites of insulin pump use in a child with Type 1 diabetes | Zendy

Perez Victoria A. | Zendy; Husain Sameera | Zendy; Magro Cynthia M. | Zendy; Strom Mark A. | Zendy; Williams Kristen M. | Zendy; Levin Laura E. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

A newly described cutaneous reaction at sites of insulin pump use in a child with Type 1 diabetes

Author(s) -

Perez Victoria A.,

Husain Sameera,

Magro Cynthia M.,

Strom Mark A.,

Williams Kristen M.,

Levin Laura E.

Publication year - 2020

Publication title -

pediatric dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.542

H-Index - 73

eISSN - 1525-1470

pISSN - 0736-8046

DOI - 10.1111/pde.14438

Subject(s) - medicine , insulin pump , insulin , type 1 diabetes , diabetes mellitus , adverse effect , continuous glucose monitoring , pyogenic granuloma , intensive care medicine , dermatology , surgery , endocrinology , lesion

Continuous subcutaneous insulin infusion (CSII), or insulin pumps, with or without continuous glucose monitoring (CGM) devices have become the standard of care for patients with type 1 diabetes. While increasingly popular, a wide range of reported skin reactions to CSII and CGM devices was found. We present this case of a pyogenic granuloma‐like neutrophilic and granulomatous response to an insulin pump to increase awareness of a previously uncharacterized cutaneous adverse reaction at insulin pump infusion sites.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research